233 related articles for article (PubMed ID: 29125867)
1. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.
Cheng YH; Eby JM; LaPorte HM; Volkman BF; Majetschak M
PLoS One; 2017; 12(11):e0187949. PubMed ID: 29125867
[TBL] [Abstract][Full Text] [Related]
2. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
Bach HH; Wong YM; Tripathi A; Nevins AM; Gamelli RL; Volkman BF; Byron KL; Majetschak M
Mol Med; 2014 Oct; 20(1):435-47. PubMed ID: 25032954
[TBL] [Abstract][Full Text] [Related]
3. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
[TBL] [Abstract][Full Text] [Related]
4. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
[TBL] [Abstract][Full Text] [Related]
5. Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists.
Eby JM; Abdelkarim H; Albee LJ; Tripathi A; Gao X; Volkman BF; Gaponenko V; Majetschak M
Mol Cell Biochem; 2017 Oct; 434(1-2):143-151. PubMed ID: 28455789
[TBL] [Abstract][Full Text] [Related]
6. G protein activation via chemokine (C-X-C motif) receptor 4 and α
Gao X; Majetschak M
FEBS Lett; 2023 Aug; 597(15):2017-2027. PubMed ID: 37395117
[TBL] [Abstract][Full Text] [Related]
7. Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia-reperfusion injury and hemorrhage.
Babu FS; Liang X; Enten GA; DeSantis AJ; Volkman BF; Gao X; Majetschak M
Sci Rep; 2020 Jul; 10(1):11359. PubMed ID: 32647374
[TBL] [Abstract][Full Text] [Related]
8. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
Gravel S; Malouf C; Boulais PE; Berchiche YA; Oishi S; Fujii N; Leduc R; Sinnett D; Heveker N
J Biol Chem; 2010 Dec; 285(49):37939-43. PubMed ID: 20956518
[TBL] [Abstract][Full Text] [Related]
9. α
Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
[TBL] [Abstract][Full Text] [Related]
10. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12.
Del Molino Del Barrio I; Wilkins GC; Meeson A; Ali S; Kirby JA
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30441765
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a chimeric chemokine as a specific ligand for ACKR3.
Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M
J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (C
Gao X; Cheng YH; Enten GA; DeSantis AJ; Gaponenko V; Majetschak M
J Biol Chem; 2020 Oct; 295(44):14893-14905. PubMed ID: 32839271
[TBL] [Abstract][Full Text] [Related]
14. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
Schafer CT; Chen Q; Tesmer JJG; Handel TM
Mol Pharmacol; 2023 Oct; 104(4):174-186. PubMed ID: 37474305
[TBL] [Abstract][Full Text] [Related]
15. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
[TBL] [Abstract][Full Text] [Related]
17. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3.
Zarca AM; Adlere I; Viciano CP; Arimont-Segura M; Meyrath M; Simon IA; Bebelman JP; Laan D; Custers HGJ; Janssen E; Versteegh KL; Buzink MCML; Nesheva DN; Bosma R; de Esch IJP; Vischer HF; Wijtmans M; Szpakowska M; Chevigné A; Hoffmann C; de Graaf C; Zarzycka BA; Windhorst AD; Smit MJ; Leurs R
Mol Pharmacol; 2024 Mar; 105(4):301-312. PubMed ID: 38346795
[TBL] [Abstract][Full Text] [Related]
19. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
[TBL] [Abstract][Full Text] [Related]
20. CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma.
Rusetska N; Kowalski K; Zalewski K; Zięba S; Bidziński M; Goryca K; Kotowicz B; Fuksiewicz M; Kopczynski J; Bakuła-Zalewska E; Kowalik A; Kowalewska M
J Clin Pathol; 2022 May; 75(5):324-332. PubMed ID: 33692092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]